FTSE MIB
33.154,05 -32,84 (-0,10%) Dow Jones
39.118,86 -45,20 (-0,12%) Nasdaq
17.732,60 -126,08 (-0,71%) Nikkei 225
39.583,08 +241,54 (+0,61%) Petrolio
81,46 -0,28 (-0,34%) Bitcoin EUR
56.571,37 -1.042,68 (-1,81%)
LFVN Sep 2024 10.000 call
- GlobeNewswire
LifeVantage Sends Letter to Stockholders and Releases Investor Presentation Detailing Success of Ongoing Transformation
The presentation can be viewed by scanning the QR code The presentation can be viewed by scanning the QR code Highlights Decisive Actions Taken by Board to Rebuild Senior Leadership Team and Develop New LV360 Strategy That Is Delivering Results Urges Stockholders to Vote “FOR” LifeVantage’s Seven Highly Engaged Directors on the WHITE Universal Proxy Card SALT LAKE CITY, Oct. 16, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company,”), a leading health an
- GlobeNewswire
LifeVantage “All In” Global Convention 2023 Showcases Next Phases of LV360, Consultant Training, Product Reveals, New Sales Incentives, and More
Convention hosted in San Antonio, TX, October 5-7, attended by over 2,000 Independent Consultants from around the worldSALT LAKE CITY, Oct. 09, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced the successful conclusion of their annual Global Convention, held from October 5-7, 2023, in San Antonio, TX. Over 2,000 LifeVantage Consultants
- GlobeNewswire
LifeVantage Directors Who Are Not Targeted by Dissident Stockholder Encourage LifeVantage Stockholders to Vote for All of the Board’s Director Candidates
Send Letter to Stockholders Detailing the Value Delivered by the Targeted DirectorsSALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today publicized a letter written by four of its directors who are not being targeted by activist stockholder Radoff-Sudbury Group. In the letter, the directors express their support for the targ
